(English below) Over Vitestro Vitestro, opgericht in 2017 in Utrecht, is een pionier in de toekomst van bloedafname met de Aletta® Autonomous Robotic Phlebotomy Device (ARPD). Dit baanbrekende medische apparaat combineert geavanceerde multimodale beeldvorming (nabij-infrarood, echografie
About Vitestro Founded in 2017 in Utrecht, Vitestro is pioneering the future of blood collection with the Aletta® Autonomous Robotic Phlebotomy Device (ARPD). This groundbreaking medical device combines advanced multi-modal imaging (near-infrared, ultrasound, and Doppler ultrasound) with
About Vitestro Founded in 2017 in Utrecht, Vitestro is pioneering the future of blood collection with the Aletta® Autonomous Robotic Phlebotomy Device (ARPD). This groundbreaking medical device combines advanced multi-modal imaging (near-infrared, ultrasound, and Doppler ultrasound) with
About Vitestro Founded in 2017 in Utrecht, Vitestro is pioneering the future of blood collection with the Aletta® Autonomous Robotic Phlebotomy Device (ARPD). This groundbreaking medical device combines advanced multi-modal imaging (near-infrared, ultrasound, and Doppler ultrasound) with
About Vitestro Founded in 2017 in Utrecht, Vitestro is pioneering the future of blood collection with the Aletta® Autonomous Robotic Phlebotomy Device (ARPD). This groundbreaking medical device combines advanced multi-modal imaging (near-infrared, ultrasound, and Doppler ultrasound) with
About Vitestro Founded in 2017 in Utrecht, Vitestro is pioneering the future of blood collection with the Aletta® Autonomous Robotic Phlebotomy Device (ARPD). This groundbreaking medical device combines advanced multi-modal imaging (near-infrared, ultrasound, and Doppler ultrasound) with
Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS) is a digital transformation and technology partner of choice for industry-leading organizations worldwide. Since its inception in 1968, TCS has upheld the highest standards of innovation, engineering excellence